Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | GLA | P06280 | 5/20 | 0.59 |
| ▸ | GAA | P10253 | 5/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | CASP1 | P29466 | 3/20 | 0.59 |
| ▸ | CASP7 | P55210 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.59 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.59 |
| ▸ | ALPG | P10696 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | MCL1 | Q07820 | 7/20 | 0.56 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | CELA1 | Q9UNI1 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27886617 | 0.83 | KDM4E (0.66) | KDM4EALDH1A1GLAGAAHSD17B10 | |
| SCHEMBL2122340 | 0.81 | HSD17B3 (0.58) | KDM4EALDH1A1GLAGAAHSD17B10 | |
| SCHEMBL3724696 | 0.79 | KDM4E (0.78) | KDM4EALDH1A1GLAGAAHSD17B10 | |
| SCHEMBL27594508 | 0.76 | MCL1 (0.54) | KDM4EALDH1A1GAAHSD17B10HPGD | |
| SCHEMBL246219 | 0.76 | KDM4E (0.62) | KDM4EALDH1A1GLAGAAHSD17B10 | |
| SCHEMBL6266846 | 0.74 | KDM4E (1.00) | KDM4EALDH1A1GLAGAAHSD17B10 | |
| SCHEMBL28068602 | 0.74 | MET (0.59) | KDM4EALDH1A1GLAGAAHSD17B10 | |
| SCHEMBL17667609 | 0.74 | CUL4A (0.46) | KDM4EALDH1A1GLAGAAHSD17B10 | |
| SCHEMBL6365673 | 0.73 | MCL1 (0.68) | KDM4EALDH1A1GLAGAAHSD17B10 | |
| 4-Methylesculetin SCHEMBL29361762 | 0.72 | MCL1 (1.00) | KDM4EALDH1A1GLAGAAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8673983-B2 | Melanins synthesized chemically or via enzyme catalysis | LOYOLA UNIVERSITY CHICAGO (US) | 2014-03-18 | — | — | US | claimed |
| US-20110230562-A1 | MELANINS SYNTHESIZED CHEMICALLY OR VIA ENZYME CATALYSIS | LOYOLA UNIVERSITY CHICAGO | 2011-09-22 | — | — | US | claimed |
| EP-2256170-B1 | Tunable fluorescent UV curable gel inks containing fluorescent monomers for food packaging applications | XEROX CORP (US) | 2014-12-24 | — | — | EP | disclosed |
| US-8673983-B2 | Melanins synthesized chemically or via enzyme catalysis | LOYOLA UNIVERSITY CHICAGO (US) | 2014-03-18 | — | — | US | disclosed |
| US-8334026-B2 | Tunable fluorescent UV curable gel inks containing fluorescent monomers for food packaging applications | XEROX CORPORATION (US) | 2012-12-18 | — | — | US | disclosed |
| US-20110230562-A1 | MELANINS SYNTHESIZED CHEMICALLY OR VIA ENZYME CATALYSIS | LOYOLA UNIVERSITY CHICAGO | 2011-09-22 | — | — | US | disclosed |
| US-20100304040-A1 | TUNABLE FLUORESCENT UV CURABLE GEL INKS CONTAINING FLUORESCENT MONOMERS FOR FOOD PACKAGING APPLICATIONS | XEROX CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
| EP-2256170-A1 | Tunable fluorescent UV curable gel inks containing fluorescent monomers for food packaging applications | Xerox Corporation (US) | 2010-12-01 | — | — | EP | disclosed |
| WO-2009082735-A1 | MELANINS SYNTHESIZED CHEMICALLY OR VIA ENZYME CATALYSIS | UNIVERSITY OF CHICAGO (US) | 2009-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230562-A1 | MELANINS SYNTHESIZED CHEMICALLY OR VIA ENZYME CATALYSIS | TYR, TH, MAOA | KDM4E 1642/4885ALDH1A1 337/4885GLA 134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.